Invitae
Invitae offers genetic testing for hereditary cancer syndromes including BRCA1/2, Lynch syndrome, and other inherited cancer risks.
Get started with Invitae
How to get started
Upload your records
Pathology, genomics, imaging — whatever you have. We extract the clinical details automatically so nothing gets retyped. Upload records →
Share with Invitae
We package your records into a secure, HIPAA-compliant bundle and pre-fill the intake. You review and sign — that's it. Share records →
Invitae reaches out
Their team confirms next steps directly with you — testing, scheduling, consultation, or enrollment.
What they offer
- Invitae offers genetic testing for hereditary cancer syndromes including BRCA1/2, Lynch syndrome, and other inherited cancer risks.
- Find out whether there are unique genes to you that would cause you to avoid a drug or increase or lower your dosage.
Coverage, insurance & cost
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Invitae handles billing.
Accepted
In-network carriers
Understand this before you decide
Ask about this service
Answers grounded in Invitae's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Who this is for
Cancer types served
Common questions in this category
Based on what other patients have asked.
When is a pet/ct scan advised for a new breast cancer diagnosis
Breast CancerDoes the specific variant of the CHEk2 mutation make a difference? I have the Ashkenazi Founder variant.
Is the CHEK2 mutation related to prostate cancer
What lifestyle changes are recommended for Prostate - Early Stage patients
Prostate - Early StageWhat should I know as a newly diagnosed CRC patient
Colorectal CancerWhat should I ask my oncologist after a new diagnosis
Also consider
Other providers in similar categories.
Tempus
5 offeringsTempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Foundation Medicine
4 offeringsFoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
BostonGene
5 offeringsTarget immunotherapies with the highest likelihood of response
Protean Biodiagnostics
3 offeringsMatches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
Get personalized guidance for your case
This page is general information. Upload your records for analysis specific to YOUR diagnosis.